Recombinant human synovial fluid phospholipase A2 and N-terminal variant: kinetic parameters and response to inhibitors. 1993

F Märki, and V Hanulak
Research Department, Ciba-Geigy Ltd., Basel, Switzerland.

To further explore the role of the N-terminus of group II phospholipase A2 (PLA2) for enzymatic activity, kinetics of recombinant human synovial fluid PLA2 (rPLA2) and a variant with an extra N-terminal methionine (Met-rPLA2) were analyzed with the substrates [1-14C]oleate-labeled Escherichia coli, vesicular phosphatidylethanolamine, and micellar phosphatidylcholine. While N-terminal variation did not affect assay parameters such as pH-optimum, or optimal concentration of calcium and E. coli substrate, it drastically reduced maximum velocities with all three substrates, without any decrease of substrate affinities, suggesting a role of the N-terminus in the catalytic step(s) subsequent to binding of the substrate. Eleven compounds from various structural classes were found to potently inhibit both enzymes. Several of these compounds were equipotent on rPLA2 and Met-rPLA2; others had significantly lower potency on Met-rPLA2 than on rPLA2. This suggests participation of the N-terminal region of the enzyme in the mechanism of inhibition by the latter compounds. The study provides new evidence for the role of the N-terminus of group II PLA2 for catalytic activity.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010741 Phospholipases A Phospholipases that hydrolyze one of the acyl groups of phosphoglycerides or glycerophosphatidates.
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013582 Synovial Fluid The clear, viscous fluid secreted by the SYNOVIAL MEMBRANE. It contains mucin, albumin, fat, and mineral salts and serves to lubricate joints. Synovia,Fluid, Synovial,Fluids, Synovial,Synovial Fluids
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic
D054467 Phospholipases A2 Phospholipases that hydrolyze the acyl group attached to the 2-position of PHOSPHOGLYCERIDES. Lecithinase A2,Phospholipase A2
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

F Märki, and V Hanulak
February 1994, Journal of medicinal chemistry,
F Märki, and V Hanulak
April 1989, The Journal of biological chemistry,
F Märki, and V Hanulak
December 1987, Inflammation,
F Märki, and V Hanulak
December 1988, Biochemical and biophysical research communications,
F Märki, and V Hanulak
January 1990, Advances in experimental medicine and biology,
F Märki, and V Hanulak
January 1988, The Journal of rheumatology,
Copied contents to your clipboard!